Eli Lilly Canada Inc. (“Lilly”) brought an application under the Patented Medicines (Notice of Compliance) Regulations (the “NOC Regulations”) for an Order...
January 28, 2013
This was an appeal from the decision of the Federal Court which had dismissed Takeda’s application for judicial review of the Minister’s refusal to list Takeda’s...
January 23, 2013
This is the first proceeding under the Patented Medicine (Notice of Compliance Regulations) (“NOC Regulations”) brought by Apotex Inc.
January 22, 2013
The Quebec government recently announced, as part of its budget, the intended abolishment of the rule known as “BAP-15.”
January 11, 2013
On November 23, 2012, the Federal Court of Appeal upheld a prohibition order preventing the Minister of Health from issuing a Notice of Compliance to Apotex Inc.
December 04, 2012
The Federal Court heard its first industrial design case in nearly two decades in Bodum v. Trudeau.
November 16, 2012
Norton Rose Canadian Technology and Intellectual property group host a half-day seminar on November 14 in Calgary.
November 09, 2012
In a decision dated October 18, 2012, the Information and Privacy Commissioner (IPC) in Ontario released the decision, under Order PO 3120, relating to a request...
November 07, 2012
In iPolitics, Canada’s pharma patent regime is intended to operate in a balanced manner that protects the interests of innovative and generic drug manufacturers.
October 16, 2012
The Minister of Health announced the government's intention to introduce regulations that would govern the submission for and approval of "orphan" drug products.
October 04, 2012
Try searching our global site instead